13D/13G Filings - Aerovate Therapeutics Inc. (AVTE)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-07-13
1:49 pm
Purchase
2021-07-0213DAerovate Therapeutics, Inc.
AVTE
Sofinnova Venture Partners X L.P.3,760,074
16.300%
3,760,074increase
(New Position)
Filing
History
2021-07-12
5:13 pm
Purchase
2021-07-0213DAerovate Therapeutics, Inc.
AVTE
RA Capital Management, L.P.8,263,982
33.900%
8,263,982increase
(New Position)
Filing
History
2021-07-12
4:19 pm
Purchase
2021-07-0213GAerovate Therapeutics, Inc.
AVTE
Cormorant Asset Management LP2,030,691
8.320%
2,030,691increase
(New Position)
Filing
History
2021-07-12
4:03 pm
Purchase
2021-07-0213GAerovate Therapeutics, Inc.
AVTE
CITADEL ADVISORS LLC1,625,174
6.700%
1,625,174increase
(New Position)
Filing
History
Goto Prev, 0, 1